Page 89 - SDIR5 Abstract book 21 12 2021.
P. 89

POSTER PRESENTATIONS



               P49




                  The role of PLAG1 oncogene and miR-26a/miR-26b in the pathogenesis of benign salivary
                                                        gland tumors

                                  1
                                                             2
                                                                         2
                                                                                       3
                                                1
                      Nadja Nikolic , Jelena Carkic , Boban Anicic , Zoran Jezdic , Branko Dozic , Jelena Milasin 1
                      1 University of Belgrade, School of Dental Medicine, Department of Human Genetics, Belgrade, Serbia


                      2 University of Belgrade, School of Dental Medicine, Clinic for Maxillofacial Surgery, Belgrade, Serbia
                        3 University of Belgrade, School of Dental Medicine, Department of Pathology, Belgrade, Serbia

               Background: Pleomorphic adenoma (PA) and Warthin’s tumor (WT) are two common benign salivary gland
               tumors  (SGTs)  that  can  undergo  malignant  transformation.  Due  to  their  histological  diversity  and
               unpredictable behavior, they represent both diagnostic and therapeutic challenges and their pathogenesis
               is still unclear. The aim of the present study was to assess in PA and WT the levels of PLAG1 oncogene
               mRNA  and  two  microRNAs  (miR-26a  and  -26b)  known  to  interact  with  PLAG1  and  to  exhibit  either
               oncogenic    or    tumor    suppressive   behavior,   depending     on    the   tumor     type.
               Material and Methods: Relative gene expression levels of PLAG1, miR-26a and miR-26b were determined
               using quantitative real-time PCR analyses in 17 PAs and 24 WTs of the parotid glands and 7 normal salivary
               glands (NSGs). Results: PLAG1 was significantly overexpressed in both PAs and WTs compared to NSGs
               (P=0.028 and P=0.008, respectively). Levels of miR-26a were increased in both neoplasms, compared to
               NSGs, suggesting a potential oncogenic role, but without statistical significance. On the other hand, miR-
               26b was downregulated in both tumor types, suggesting its potential tumor suppressive role, but again
               without reaching statistical significance (P>0.05). Additionally, no correlation was observed between PLAG1
               expression and relative miR-26a/ miR-26b levels in neither of the examined patient groups. No association
               was found between markers’ expression and clinical/epidemiological parameters of PA and WT patients.
               Conclusion: PLAG1 role has been confirmed in both neoplasms, yet from the present study it does not
               appear that the oncogene is a target of miR-26a/miR-26b.
               Keywords: Salivary Gland Neoplasms; PLAG1; miR-26a; miR-26b; Pleomorphic Adenoma; Warthin Tumor













                                                             76
   84   85   86   87   88   89   90   91   92   93   94